StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.63+0.34 (+4.10%)

Close on Nov 17, 2026Market cap $256.91MP/E –Yield –

Q32 Bio operating margin

Operating margin is operating income as a percentage of revenue.

Q32 Bio's operating margin for the twelve months ending Jun 30, 2024 was -3570.1%. For fiscal 2025 it was 31.5%, against -4154.6% the year before. The highest annual figure on record is 31.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202531.5%+4186.1
FY2022Dec 31, 2022-4154.6%−3872.2
FY2021Dec 31, 2021-282.4%+4538.5
FY2020Dec 31, 2020-4821.0%+1778.2
FY2019Dec 31, 2019-6599.2%−5473.2
FY2018Dec 31, 2018-1126.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2023Sep 30, 2023-419.5%+3678.0
Q2 FY2023Jun 30, 2023-227.0%+3302.6
Q1 FY2023Mar 31, 2023-250.2%+4440.3
Q4 FY2022Dec 31, 2022-4301.0%−108.4
Q3 FY2022Sep 30, 2022-4097.5%−2269.2
Q2 FY2022Jun 30, 2022-3529.6%−2132.6
Q1 FY2022Mar 31, 2022-4690.5%−4686.7
Q4 FY2021Dec 31, 2021-4192.6%−1151.6
Q3 FY2021Sep 30, 2021-1828.3%+3158.1
Q2 FY2021Jun 30, 2021-1397.0%+4898.8
Q1 FY2021Mar 31, 2021-3.8%+6202.3
Q4 FY2020Dec 31, 2020-3041.0%+1498.8
Q3 FY2020Sep 30, 2020-4986.4%+2108.4
Q2 FY2020Jun 30, 2020-6295.8%+840.2
Q1 FY2020Mar 31, 2020-6206.1%+3098.7
Q4 FY2019Dec 31, 2019-4539.8%−2853.2
Q3 FY2019Sep 30, 2019-7094.8%−6118.8
Q2 FY2019Jun 30, 2019-7136.0%−6173.8
Q1 FY2019Mar 31, 2019-9304.8%−8357.4
Q4 FY2018Dec 31, 2018-1686.6%–
Q3 FY2018Sep 30, 2018-976.0%–
Q2 FY2018Jun 30, 2018-962.2%–
Q1 FY2018Mar 31, 2018-947.4%–

More Q32 Bio figures

See a number that looks wrong?